Miranda-Serrano NA, Rodríguez-Blas AI, Montaño-Alonso EA, Flores-San Martín D

Language: Spanish
References: 12
Page: 9-14
PDF size: 199.93 Kb.

ABSTRACT

Introduction: Renal biopsy is a useful tool in diagnosing benign kidney disease, assessing the extent of kidney damage and is essential for proper treatment selection and prognosis. Objective: To show the usefulness of using renal biopsy guided by USG. Material and methods: Retrospective analysis of patients undergoing renal biopsy at the radiology department, Juarez Hospital of Mexico, from January 2014 to December 2017. Results: The study period included 46 patients, 60% women, diagnostic success was 100%, 0% morbidity and mortality, glomerulonephritis lupica was the most frequent histopathologic diagnosis. Conclusion: Ultrasound-guided renal biopsy is a safe and effective method for diagnosing non-cancerous glomerular pathology.

REFERENCES

1. Johnson R, Feehally J, Floege J. Comprehensive clinical nephrology, Capítulo 6, 5th edition, Elsevier 2015, p. 71.

2. Sosa-Barrios RH, Burguera V, Rodriguez-Mendiola N, et al. Renal biopsy. BMC Nephrol 2017; 18(1): 365.

3. Feldmann Y, Böer K, Wolf G, Bushc M. Complications and monitoring of percutaneous renal biopsy- a retrospective study. Clin Nephrol 2018; 89(4): 260-8.

4. Esposito V, Mazzon G, Baiardi P, Torreggiani M, Semeraro L, Catucci D, et al. Safety and adequacy of percutaneous kidney biopsy performed by nephrology trainees. BMC Nephrol 2018; 19(1): 14.

5. Perkowska-Ptasinska A, Deborska-Materkowska D, Bartczak A, Stompor T, Liberek T, Bullo-Piontecka B, et al. Kidney disease in the elderly: biopsy based data from 14 renal centers in Poland. BMC Nephrol 2016; 17(1): 194.

6. Shah SS, Akhtar N, Ahmed T, Sunbleen F. Complications and safety of post percutaneousrenalbiopsyin paediatric patients. J Ayub Med Coll Abbottabad. 2015; 27(2): 421-4.

7. Perkowska-Ptasinska A, Bartczak A, Wagrowska-Danilewicz M, Halon A, Okon K, Wozniak A, et al. Clinicopathologic correlations of renal pathology in the adult population of Poland. Nephrol Dial Transplant 2017; 32(Suppl. 2): ii209-8.

8. Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker G, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 2012; 23(6): 727-36.

9. Chávez VV, Orizaga CC, Becerra FJ, Fuentes RF, Parra MR, Aragaki Y y cols. Epidemiología de la enfermedad glomerular en adultos. Revisión de una base de datos. Gac Med Mex 2014; 150(5): 403-8.

10. Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Addendum of newer anticoagulants to the SIR consensus guideline. J Vasc Interv Radiol 2013; 24(5): 641-5.

11. Maixnerova D, Jancova E, Skibova J, Rysava R, Rychlik I, Viklicky O, et al. Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011. J Nephrol 2015; 28(1): 39-49.

12. Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, et al. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection. BMC Nephrol 2017; 18(1): 89.